Why Cerevel Therapeutics has risen 50% in three days without changing anything
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello, everyone. Damian here with some unrest at well-funded startups, a curious biotech run-up, and long-awaited news at BIO.
